Francisco Javier Cubero

Author

Also Known As

Cubero, Francisco J., Cubero, Francisco Javier, F Cubero, F J Cubero, F. J. Cubero, F. Javier Cubero, F.J Cubero, F.J. Cubero, Francisco Cubero, Francisco J Cubero

195

Publications

Citations

H-Index

Concepts

All Affiliations

RWTH Aachen University Universidad Complutense de Madrid Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Research Institute Hospital 12 de Octubre Hospital General Universitario Gregorio Marañón

About

Francisco Javier Cubero is an author at RWTH Aachen University specializing in medicine, liver physiology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	21	1K
2	Health Sciences	3	3	150
3	Natural Sciences	3	3	105
4	Anatomy	1	1	47
5	Biochemistry	1	1	39

Francisco Javier Cubero

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis Lijun Liao, Kai Markus Schneider, Eric J. C. Gálvez, Gut	2019	171
Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC Svenja Sydor, Jan Best, I Messerschmidt, Clinical and Translational Gastroenterology	2020	126
Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents Maximilian Hatting, Gang Zhao, F. Schumacher, Hepatology	2013	115
Loss of Caspase-8 Protects Mice Against Inflammation-Related Hepatocarcinogenesis but Induces Non-Apoptotic Liver Injury Christian Liedtke, Jörg‐Martin Bangen, Julia Freimuth, Gastroenterology InflammationHepatologyLiver PhysiologyImmunologyPathology	2011	115
Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury Francisco Javier Cubero, Miguel Eugenio Zoubek, Wei Hu, Gastroenterology InflammationHepatic DisordersHepatologyLiver PhysiologyPathology	2015	105
Adiponectin accounts for gender differences in hepatocellular carcinoma incidence Elisa Manieri, Leticia Herrera‐Melle, Alfonso Mora, The Journal of Experimental Medicine PathologyMetabolic RemodelingFatty Liver DiseaseAdipokinesInsulin Signaling	2019	100
Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis Marcos F. Fondevila, Uxia Fernandez, Violeta Heras, Journal of Hepatology	2022	99
p38γ is essential for cell cycle progression and liver tumorigenesis Antonia Tomás‐Loba, Elisa Manieri, Bárbara González‐Terán, Nature Tumor BiologyLiver TumorigenesisMedicineLiver PhysiologyPathology	2019	94
Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma Roland Sonntag, Nives Giebeler, Yulia A. Nevzorova, Proceedings of the National Academy of Sciences	2018	92
Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis Yulia A. Nevzorova, Wei Hu, Francisco Javier Cubero, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Liver FibrosisHepatic Stellate CellsPathologyCholangiopathiesCirrhosis	2013	86

Page 1